Specifically, we found EPS8, DSG2, RHOD, ITGB6, ANKRD37, SELENBP1, FOXA3, and ALDH1A1 could be potential biomarkers to accurately predict the prognosis of pancreatic cancer patients. The gene discussed is RHOD; the disease is pancreatic neoplasm.